News & Perspective

May 17, 2019

May 17, 2019

ASP Scan (Weekly) for May 17, 2019

Northern Ireland AMR plan
Rapid susceptibility tests
Unnecessary abx for respiratory infections
Antibiotics in school beef
UK veterinary stewardship policy
Improper prescribing in seniors
Resistant TB testing in China
Antibiotic production partnership
MCR-1 in chickens, camels
New CARB-X funding
Grant for TB research

May 15, 2019

May 15, 2019

News Scan for May 15, 2019

UK veterinary stewardship policy
Improper prescribing in seniors
Resistant TB testing in China
Antibiotic production partnership
MCR-1 in chickens, camels

Aug 06, 2018

Aug 06, 2018

News Scan for Aug 06, 2018

Saudi MERS cases
Echovirus in Europe
Variant flu in California
H5 avian flu in Asia

Sep 22, 2017

Sep 22, 2017

ASP Scan (Weekly) for Sep 22, 2017

One Health stewardship
MRSA risk in the home
Resistant farm E coli in China
MDR malaria spread
Pediatric antimicrobial stewardship
New US Candida auris cases
Post-cesarean antibiotics
Point-of-care testing
Pneumonia vaccine and antibiotics
New vaginosis antibiotic
Gene sequencing for CRE
C diff and tetracyclines
Resistant E coli clone in kids
New pneumonia antibiotic
UK strep guidelines

Aug 16, 2007

Aug 16, 2007

Glaxo sells more H5N1 vaccine to US, launches trial

(CIDRAP News) – The British pharmaceutical company GlaxoSmithKline (GSK) recently announced another major order of prepandemic H5N1 influenza vaccine from the US Department of Health and Human Services (HHS), along with plans to launch a North American clinical trial of the vaccine.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»